Trial intelligence / Profile preview

TRAM study of cyclosporine AUC versus trough monitoring after allogeneic stem cell transplantation

NL-OMON27177Active, not recruiting

Sponsor
Vrije University Medical Center
Start
Jun 2014
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Randomised, open-label trial of cyclosporine in graft-versus-host disease (GVHD), sponsored by Vrije University Medical Center. Started Jun 2014; status: active, not recruiting.

02

Drugs

cyclosporine
03

Conditions

graft-versus-host disease (GVHD)

Beyond the preview

Go deeper on NL-OMON27177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON27177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call